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Abstract
Background: Restorative proctocolectomy with ileopouch-anal anastomosis (IPAA) is the treatment of choice for
intractable or complicated ulcerative colitis (UC). Debate exists concerning outcomes of IPAA in the elderly and
literature data are scarce. We report our experience of IPAA in older population.
Methods: We gathered data on a prospective database of patients undergoing IPAA for UC over 70 years of age
in our Unit from January 1990 through January 2010. Patients were compared with randomly selected younger
controls on a 1:3 ratio. Patients underwent IPAA in 2 or 3 stages. Demographical data, disease characteristics,
comorbidities, concomitant medications, peri-operative management, intra- and post-operative complications were
analyzed. Function and quality of life were assessed by clinical visit and Inflammatory Bowel Disease Questionnaire
1 and 3 years after ileostomy takedown.
Results: Twenty-seven elderly patients underwent IPAA for UC in the study period; these were compared with 81
younger controls. The former had more comorbidities and higher ASA score. All patients underwent loop-
ileostomy closure. There were no differences between groups concerning the rate of major complications, but
elderly patients more frequently had nuisances due to stoma output. Younger patients experienced significantly
more episodes of small bowel obstruction. No significant differences in bowel control and health-related quality of
life was observed, except for an higher rate of elderly patients taking antidiarrhoeals at 1-year follow-up; this
observation was not confirmed at 3-year follow-up. A minimal decrease in continence was observed, but this did
not affect overall satisfaction.
Conclusions: IPAA can be safely offered to selected elderly UC patients who are strongly motivated and with no
clinical disturbances of continence. In experienced hands no differences are likely to be expected concerning
complications, quality of life and function. Results are stable with time and comparable to those of younger patients.
Background
Restorative proctocolectomy with ileo-pouch-anal ana-
stomosis (IPAA) is the procedure of choice for compli-
cated or refractory ulcerative colitis (UC) [1,2]. Recent
data suggest that IPAA is suitable also in patients in the
elderly; however, in published series patients are often
classified as “in the elderly” when aged >45 years [2-5].
Furthermore, debate exists concerning peri-operative
morbidity, bowel function and quality of life in this sub-
group of patients.
Aim of our study was to compare the outcome of
IPAA in patients undergoing surgery >70-year-old with
those aged <70 with respect to perioperative complica-
tions and function over time, and to demonstrate that
this procedure is safe and effective also in the elderly.
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Methods
We gathered data from the prospective database of
patients undergoing IPAA for UC aged >70 years in our
Unit from January 1990 through January 2010. Patients
were compared with randomly selected younger controls
on 1:3 ratio. Two groups were established on the basis
of chronological age: group A ≥70 years, group B < 70
years. Life expectancy in Italy is approximately 78.90
(78.70-79.10) years in male and 83.90 (83.70-84.10) in
female population, and similar data are found across
Europe [6]. We assumed 70 years as a threshold in our
analysis as a person is usually unable to cope with work
or is retired by the age of 70. Demographical data, dis-
ease characteristics, comorbidities, concomitant medica-
tions, peri-operative management, intra- and post-
operative complications were thoroughly collected.
Surgical pathway
Surgery was performed in 2 stages (1: proctocolectomy
with IPAA and loop-ileostomy; 2: ileostomy takedown) or
in 3 stages (1: subtotal colectomy with terminal ileostomy;
2: completion proctectomy, IPAA and loop-ileostomy; 3:
ileostomy takedown). Completion proctectomy with
IPAA was performed 6-7 months after colectomy; loop-
ileostomy takedown was performed 2-3 months after
IPAA. Patients undergoing 1-stage and 2-stage modified
IPAA were excluded from the study.
Postoperative evaluation
Perioperative complications and mortality were defined as
complication and decease occurring between surgical
intervention and discharge. Function was assessed during
office visit 6 months after ileostomy closure then yearly
for at least 3 years. Visits consisted of clinical exam,
including digital examination of the IPAA and flexible
pouchoscopy. All patients completed Inflammatory Bowel
Disease Questionnaire (IBDQ) to assess health-related
quality of life (HRQoL) after ileostomy takedown [7,8].
Statistical analysis
Results are expressed as or mean ± SD unless otherwise
indicated. For continuous parameters t-test was used.
Comparisons between categorical variables were ana-
lyzed using the Fisher’s exact test. P <.05 was considered
statistically significant.
Results
Twenty seven patients aged over 70 years underwent
IPAA in the study period and were included in Group
A; they were compared with 81 younger controls
(Group B). Details of patients and surgical procedure
are reported in table 1. Group A patients had more
comorbidities and higher ASA score. All patients under-
went loop-ileostomy closure. No detrimental effect was
observed, except for two patients excluded from 3-year
follow-up: one dead because of an acute myocardial
infarction 2 years after IPAA, another one needed
pouch excision because of intractable pouchitis.
Complications are depicted in table 2. There was no
intraoperative or perioperative mortality. No differences
between groups concerning the rate of major complica-
tions were observed. Elderly patients suffered more fre-
quently for dehydration due to stoma output; this
required readmission in one Group A patient. Younger
patients experienced significantly more episodes of small
bowel obstruction, but only in one case surgery was
Table 1 Characteristics of Patients by Age
Characteristics Group A >70 (n 27) Group B <70 (n 81) P value
mean (± SD)
age, years







BMI, mean (± SD) 20.5 (±3.6) 21 (±5.7) 0.22
sex, n (M/F) 12/15 32/49 0.66
use of steroids at time of surgery, n (%) 13 (48.1) 31 (38.3) 0.37
use of azathioprine at time of surgery, n (%) 1 (3.7) 0 (0) 0.25
use of other-than-anti-UC drugs, n (%) 16 (59.3) 31 (38.3) 0.07
comorbidities, n (%) 24 (88.9) 21 (17.3) <0.0001
hypoalbuminemia, n (%) 8 (29.6) 16 (19.7) 0.29
ASA score ≥ III, n (%) 9 (33.4) 5 (6.2) 0.001
3-stage procedure, n (%) 5 (18.5) 12 (14.8) 0.76
hand-sewn anastomosis, n (%) 9 (33.4) 31 (38.3) 0.82
SD: standard deviation
BMI: body mass index
UC: ulcerative colitis
ASA: American Society of Anesthesiologist
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advocated. Function and HRQoL over time are reported
in table 3. At 1-year follow-up elderly patients were tak-
ing significantly more antidiarrhoeal medications, but
this observation was not confirmed at 3-year follow-up.
A minimal decrease in continence was observed, but
this did not affect overall satisfaction and HRQoL.
Discussion
IPAA is the mainstay treatment for intractable or com-
plicated UC. It cures UC removing the entire diseased
mucosa and controls some extra-intestinal manifesta-
tions. The risk of cancer is eliminated, provided that
dysplasia or cancer are not present and not overlooked
in the operative specimen [9].
IPAA is a complex procedure, requiring extensive
expertise. High-volume operating teams achieve better
results than surgeons performing IPAA sporadically
[10]. Several complications may affect the outcome of
surgery, pelvic sepsis being the most worrisome. Pelvic
sepsis is reasonably considered the bête noire of IPAA
[11], negatively impacting on function and HRQoL and
potentially leading to failure, but recent advancements
have led to a dramatic reduction of septic complications,
currently happening in less than 25% of patients (7.7%
failure) [12,13]. In our series, elderly patients were not
at higher risk of sepsis. There still exists skepticism to
recommend IPAA in the elderly. This may be justified
by several reasons. First of all, evidences on IPAA in
elderly patients are definitively lacking in the literature.
Older patients are often found with comorbidities - as
confirmed in our report - and this is believed to increase
the risk of postoperative complications. There is a phy-
siological decrease in sphincter function in older per-
sons, which may lead to worse bowel control. These
observations led some authors to recommend ileo-rectal
anastomosis in elderly UC patients [14,15].
We are able to confute these points in the light of our
results.
Table 2 Postoperative Complications by Age
Group A Group B P
>70 (n 27) <70 (n 81) value
Perioperative morbidity
Minor
Prolonged ileus 7 (25.9) 24 (29.6) NS
Electrolytes loss from stoma output 14 (51.8) 19 (23.4) 0.008
Surgical wound infection 1 (3.7) 2 (2.5) NS
Major
Hemorrhage 0 (0) 2 (2.5) NS
Anastomotic leak 1 (3.7) 3 (3.7) NS
Compartment syndrome of lower limb 0 (0) 1 (1.2) NS
Systemic morbidity
Asymptomatic pancreatitis 1 (3.7) 1 (1.2) NS
Symptomatic portal vein thrombosis 0 (0) 1 (1.2) NS
PE 1 (3.7) 1 (1.2) NS
UTI 1 (3.7) 3 (3.7) NS
PI 2 (7.4) 4 (4.9) NS
AMI 0 (0) 1 (1.2) NS
Late postoperative morbidity
SBO 1 (3.7) 17 (20.1) 0.04
Anastomotic stricture 3 (11.1) 6 (7.4) NS
Chronic/recurrent pouchitis 2 (7.4) 7 (9.8) NS
Pouch-vaginal fistula 0/15 (0) 1/49 (2) NS
Symptomatic retained rectal stump 0 (0) 1 (1.2) NS
Twisting reservoir 1 (3.7) 0 (0) NS
NS: not significant
PE: pulmonary embolism
UTI: urinary tract infection
PI: pulmonary infection
AMI: acute myocardial infarction
SBO: small bowel obstruction
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The lack of evidences is a fact. Farouk et al. [4] found
patients undergoing IPAA in the elderly suffering from
higher stool frequency, fecal incontinence, pad usage,
need for constipating medication. Similar results were
reported by Delaney et al [5], although differences
seemed less apparent at 10-year follow-up. However,
even if these are the most cited studies on the topic,
due to the large number of observed patients, it should
be remarked that they consider patients as “in the
elderly” if over 45 or 50 years of age. We chose 70 years
of age as a cut-off value, adjusting it on the basis of life
expectancy, as it is more reliably including patients who
are actually in an elderly condition (i.e. not able to cope
with work activity), reflecting an higher rate of comor-
bidities and need for concomitant medications.
Comorbidities and concomitant medications may be
an issue. In our series patients aged over 70 years were
found with a significantly higher number of comorbid-
ities, but this observation did not affect the outcome of
surgery or HRQoL. Rather than considering comorbid-
ities alone, one should assess general performance sta-
tus, and offer IPAA only to suitable patients. The ideal
candidate for IPAA should be autonomous, with no
symptomatic sphincter disturbance, able to understand
the risks and problems of the procedure, and willing to
trade on surgery [2,4,5]. Older UC patients often need
to take more than one drug [16] and are at risk of
developing complications from drug interactions (i.e.
azathioprine plus ACE-inhibitors increases the risk of
leukopaenia and anemia [17]) and from prolonged
Table 3 Function and Quality of Life by Age at 1-Year and 3-Year Follow-Up




1-year follow-up n (%) n (%)
Function
Mean stool frequency per day (±SD) 4.6 (±2.1) 4.8 (±2.3) NS
Patients with night evacuation 7 (25.9) 20 (24.7) NS
Urgency 2 (7.4) 6 (7.4) NS
Incontinence during day 1 (3.7) 2 (2.5) NS
Incontinence during night 2 (7.4) 2 (2.5) NS
Impaired discrimination 6 (22.3) 15 (18.5) NS
Pad 7 (25.9) 18 (22.3) NS
Antidiarrhoeals 14 (51.9) 23 (28.4) 0.03
IBDQ
Excellent/Good (>150) 16 (59.3) 52 (64.2) NS
Regular (101-150) 10 (37) 27 (33.3) NS
Bad (<101) 1 (3.7) 2 (2.5) NS
Group A* Group B* P
>70 (n 26) <70 (n 80) value
3-year follow-up n (%) n (%)
Function
Mean stool frequency per day (±SD) 4.8 (±2.2) 4.9 (±1.9) NS
Patients with night evacuation 7 (26.9) 21 (26.2) NS
Urgency 3 (11.5) 9 (11.2) NS
Incontinence during day 1 (3.8) 2 (2.5) NS
Incontinence during night 2 (7.7) 2 (2.5) NS
Impaired discrimination 7 (26.9) 17 (21.2) NS
Pad 6 (23) 19 (23.7) NS
Antidiarrhoeals 12 (46.1) 24 (30) NS
IBDQ
Excellent/Good (>150) 14 (53.8) 48 (60) NS
Regular (101-150) 11 (42.3) 30 (37.5) NS
Bad (<101) 1 (3.9) 2 (2.5) NS
*One patient of each group was lost at 3-year follow-up: 1 Group A patient needed pouch excision for intractable pouchitis; 1 Group B patients died for myocardial
infarction 2 years after surgery.
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consumption of medications (i.e. immunosuppressants
and higher risk for malignancies [16,18]). IPAA has a
protective effect on such complications, ensuring the
avoidance of drugs to control UC-related symptoms. In
our series, at 1-year follow-up elderly patients were
more frequently taking antidiarrhoeals. Older patients
may be used to “take drugs” to cope with disturbances
or, more probably, with their fears. As long as they
become conscious of their condition, and used to a new
bowel functioning, a decrease or stabilization of anti-
diarrhoeals assumption is likely to be observed (table 3).
Some peculiar aspects of elderly patients undergoing
ileal diversion need to be discussed. We found a signifi-
cant rate of dehydration in older patients with a stoma;
one patient required readmission and intravenous fluid
administration. Elderly patients may be under treatment
with hypotensive agents preoperatively: reintroduction
of the drugs is to be done carefully. Also, older indivi-
duals often have an impaired thirst mechanism. Dehy-
dration must not be overlooked and should be promptly
treated; electrolytes imbalance may potentially lead to
dramatic consequences. Patients should be aware of the
risk. Ileostomy takedown should be performed as soon
as possible, taking into account the completeness of
IPAA maturation period and patients’ health status.
Continence tends to decrease in the elderly. However,
it is important to investigate for symptomatic distur-
bances and not to overestimate them [19]. In details,
patients with active or severe disease, with frequent
emission of semi-liquid, hematic stools, may suffer from
seepage and soiling. The frequent passage of irritating
substances may cause this effect, and be misleading, and
clinicians may overestimate the rate of incontinence:
when the disease is controlled, continence is promptly
restored. This contingent stool loss must be differen-
tiated from actual impairment of continence, and an
accurate examination by an expert surgeon allows for it.
Also, when treating patients with lower life expectancy,
the functional outcome might be more important than
the potential long-term risk of malignancy: the preserva-
tion of the small rectal mucosa cuff and of the anal
transitional zone by the double-stapled technique yields
better functional outcomes and is to be preferred. This
is the ideal situation for making an anastomosis at the
upper canal level - where there may be better function.
Conclusions
When dealing with older patients, it should always been
considered that a well-functioning ileostomy may be pre-
ferable over an IPAA with poor functional outcome and
incontinence. IPAA should be offered selectively to elderly
UC patients who are strongly motivated and with no clini-
cal disturbances of continence. When these conditions are
respected, no differences are observed in terms of
complications and HRQoL. Once indications to surgery are
established, IPAA is to be encouraged in suitable patients,
as delaying the operation may result in sub-optimal out-
comes, irrespective of age.
In our series we found IPAA safe and with excellent
functional results in selected elderly patients. Results are
stable with time. Function and quality of life are com-
parable to those of younger patients.
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